Girish Kalva
Internal Medicine · Holladay, UTNPI 1821059544
Payments from drug & device makers
Across 50 payments — averaging $32.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Access Systems, Inc.$500
- Grifols USA, LLC$265
- QOL Medical, LLC$145
- Jazz Pharmaceuticals Inc.$132
- Idorsia Pharmaceuticals US Inc$70
- Renalytix AI, Inc.$70
- plus $467 from 15 others
What the payments were for
- Speaking & faculty fees$50030%
- Food & beverage$1,14970%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Access Systems, Inc. | 1 | $500 |
| Grifols USA, LLC | 9 | $265 |
| QOL Medical, LLC | 7 | $145 |
| Jazz Pharmaceuticals Inc. | 1 | $132 |
| Idorsia Pharmaceuticals US Inc | 4 | $70 |
| Renalytix AI, Inc. | 2 | $70 |
| Harmony Biosciences LLC | 3 | $67 |
| AstraZeneca | 4 | $56 |
| Lilly USA, LLC | 3 | $50 |
| Pfizer | 3 | $46 |
| AbbVie | 2 | $43 |
| Antares Pharma, Inc. | 2 | $41 |
| Corcept Therapeutics | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Sanofi | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$132
How this compares
$1,649 in reported general payments places this provider in the 75th percentile of 496 internal medicine providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 15 | $9,088 |
| ProgesteroneProgesterone, Micronized | 19 | $1,575 |
| Liothyronine Sodium | 25 | $711 |
| Levothyroxine Sodium | 56 | $634 |
| Allopurinol | 28 | $280 |
| Mirtazapine | 18 | $267 |
| Losartan Potassium | 23 | $208 |
| Fluconazole | 11 | $141 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Holladay
- Ahad SabetSalt Lake City$34.5M
- Barbara RizzardiSandy$27.8M
- Willard DereSalt Lake City$4.7M
- Joseph WoolleySaint George$3.6M
- Justin MansfieldOgden$3.1M
- Michael KillpackSandy$2M
- Cuper Martinez SantibanezWest Valley City$1M
- Joshua OaksBountiful$973K
- Brandon WebbSalt Lake City$544K
- Yong Hui AhnSlc$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.